Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 08, 2005. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons regarding their interests in the company's ordinary shares.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of insider trading and trust movements rather than a financial performance statement.
Material Changes
The filing details specific changes in shareholdings for the following individuals and entities:
- Rupert Bondy: Acquired a beneficial interest in 2 ordinary shares on July 04, 2005, via a Personal Equity Plan at a price of £13.45 per share.
- Julian Heslop: Acquired 4 ordinary shares on July 07, 2005, via a Single Company ISA at a price of £13.62 per share.
- GlaxoSmithKline US Retirement Savings Plan: The number of Ordinary Share ADRs held by the fund decreased from 18,354,038 to 18,343,942 on July 07, 2005, due to a fund movement at an average price of $48.24. Directors Dr. J.P. Garnier and Dr. T. Yamada are noted as potentially interested in these shares.
- GlaxoSmithKline Employee Trust (GSK Trust): Transferred 8,396 ordinary shares to participants in the SmithKline Beecham Employee Share Option Plan 1991 on July 08, 2005. Directors Dr. J-P Garnier, Dr. T. Yamada, and Mr. J.S. Heslop are noted as potentially interested in shares held in this trust.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to regulatory notifications of share transactions.
Key Facts for Investor Verification
- Verify the current share price relative to the transaction prices disclosed (£13.45, £13.62, and $48.24 ADR) to assess the timing of insider purchases.
- Confirm the total number of shares held by the US Retirement Savings Plan and the GSK Trust to understand the scale of employee-related holdings.
- Note that the transactions involving the US Retirement Savings Plan and the GSK Trust involve potential interests for multiple directors, including Dr. J.P. Garnier, Dr. T. Yamada, and Mr. J.S. Heslop.